LONDON--(BUSINESS WIRE)--Sep 27, 2019--
The global eye infections therapeutics market size is poised to grow by USD 342.39 billion during 2019-2023, according to a new report by Technavio, progressing at a CAGR of 3% during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190927005126/en/
Technavio has announced its latest market research report titled global eye infections therapeutics market 2019-2023. (Graphic: Business Wire)
Read the 149-page research report with TOC on "Eye Infections Therapeutics Market Analysis Report by type (Conjunctivitis, Keratitis, and Blepharitis) and geography (North America, Europe, Asia, and ROW) 2019 - 2023" at:
The market is driven by the rising geriatric population. Also, the rising number of government initiatives is anticipated to further boost the growth of the market during the forecast period.
To learn more about the global trends impacting the future of market research, Download Free Sample
At present, the geriatric cohort forms a large fraction of the population that is vulnerable to eye infections, as people are more prone to ophthalmic problems as they age. Although eye infections account for a significant proportion of these ophthalmic problems, there is a little clinical information in studies on infections, such as conjunctivitis and keratitis, among the elderly. Eye infection patients aged over 60 years generally need special medical attention as the condition can become more severe at that age. Thus, the number of visits to ophthalmologists from people belonging to this age group is high, which is a major factor driving the global eye infections therapeutics market.
Furthermore, government organizations worldwide are conducting several programs to spread awareness about ophthalmic diseases. Loss of sight is one of the major subjects of concern for the government in many countries, as around 80% of blindness is preventable and/or treatable. For instance, the Ministry of Health and Family Welfare, Government of India, has set up the National Programme for Control of Blindness & Visual Impairment to improve public awareness on eye care and provide comprehensive eye care services. There are numerous such programs across the world, which provide free eye check-ups and arrange mobile eye camps for the treatment of eye infections in the interest of public health. Most of the drugs, antibacterial gels, and eye drops offered for eye infections under these programs are heavily subsidized or are provided free-of-cost. Thus, such initiatives are expected to drive market growth largely during the forecast period.
To find out more about Eye Infections Therapeutics Market Research 2019-2023,https://www.technavio.com/talk-to-us?report=IRTNTR32102
The report includes detailed profiles of the leading companies & prominent vendors of the market:
- Akorn Inc.
- Allergan Plc
- Bausch Health Companies Inc.
- Bayer AG
- Daiichi Sankyo Co. Ltd.
- GlaxoSmithKline Plc
- Novartis AG
- Pfizer Inc.
- Santen Pharmaceutical Co. Ltd.
Market Segmentation by Category and Product Types:
The Eye Infections Therapeutics Market can be broadly categorized into the following:
Key Regions for the Eye Infections Therapeutics Market:
Featuring a breakdown of region-wise market shares until 2019.
- North America
Register for a free trial today and gain instant access to 10,000+ market research reports.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Related Reports on Healthcare Market are:
Eye Allergy Therapeutics Market – Global Eye Allergy Therapeutics Market by product (Antihistamines, Mast cell stabilizers, Corticosteroids, Immunomodulators, and Others) and geography (Asia, Europe, North America, and ROW).
Artificial Eye Market – Global Artificial Eye Market by geography (Americas, EMEA, and APAC) and product (integrated prosthetic eye, non-integrated prosthetic eye, and retinal prosthetics)
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190927005126/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: SCIENCE PHARMACEUTICAL RESEARCH OPTICAL HEALTH INFECTIOUS DISEASES
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 09/27/2019 05:00 AM/DISC: 09/27/2019 05:01 AM